BELLICUM PHARMACEUTICALS, INC
BELLICUM PHARMACEUTICALS, INC (BLCM) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 215 transactions totaling $20.9M, demonstrating a bearish sentiment with -$16.6M in net insider flow. The most recent transaction on Nov 22, 2023 involved a transaction of 174,742 shares valued at $0.
BLCM Insider Activity Summary
Who Is Buying BLCM Stock?
No significant insider buying has been recorded for BLCM in the recent period.
Who Is Selling BLCM Stock?
No significant insider selling has been recorded for BLCM in the recent period.
Is BELLICUM PHARMACEUTICALS, INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BLCM is bearish with an Insider Alignment Score of 10/100 and a net flow of -$16.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
BLCM Frequently Asked Questions
Understanding BLCM Insider Activity
Insider trading at BELLICUM PHARMACEUTICALS, INC (BLCM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading BLCM stock, having executed 215 transactions in the past 90 days. The most active insider is Bros. Advisors (gp) Llc Baker (Executive), who has made 11 transactions totaling $7.2M.
Related Tools
Track BELLICUM PHARMACEUTICALS, INC Insider Activity
Get notified when executives and directors at BLCM file new Form 4 transactions